Home › Bladder Cancer › Illinois › Champaign
Bladder Cancer clinical trials in Champaign, IL
4 studies for Bladder Cancer are looking for participants at sites in and around Champaign (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Carle Cancer Center, Urbana · 2 mi away
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
RecruitingPhase 2
- Carle Cancer Center, Urbana · 2 mi away
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
RecruitingPhase 2
- Carle Cancer Center, Urbana · 2 mi away
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- Carle Cancer Center, Urbana · 2 mi away
About Bladder Cancer
Bladder cancer symptoms range from lower back pain to blood in your urine. Read about important risk factors and find a list of treatments available
More about Bladder Cancer on MedlinePlus
Bladder Cancer trials in other cities
- New York City, NY35 studies
- Nashville, TN31 studies
- Houston, TX31 studies
- Dallas, TX27 studies
- Boston, MA26 studies
- Washington, DC26 studies
- Los Angeles, CA24 studies
- Baltimore, MD24 studies
- St. Louis, MO22 studies
- Philadelphia, PA21 studies
- Seattle, WA21 studies
- Edison, NJ21 studies
Other studies in Champaign
- Non-Small Cell Lung Cancer11 studies
- Breast Cancer11 studies
- Lung Cancer9 studies
- Prostate Cancer8 studies
- Endometrial Cancer6 studies
- Cancer (all types)6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Melanoma6 studies
- Colorectal Cancer6 studies
- Laryngeal Cancer5 studies
- Oral Cancer5 studies
- Kidney Cancer (Renal Cell Carcinoma)5 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.